NCT00064129 2020-07-30Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate CancerNational Cancer Institute (NCI)Phase 1 Completed42 enrolled
NCT00274287 2019-03-28GM-CSF for Maintenance of Prostate Cancer for Patients Responding to TaxotereOncology Specialists, S.C.Phase 2 Completed15 enrolled 12 charts